Tag: GENESIS-II study
GENESIS-II Study reveals exceptional 30-day results for the Hydra self-expanding transcatheter...
Findings presented at EuroPCR 2024 showcase the exceptional safety and efficacy of the Hydra THV, offering renewed hope for patients with severe aortic stenosis